Company
Headquarters: Tainan City, Taiwan
Employees: 30
TW$3.42 Billion
TWD as of July 1, 2024
US$105.1 Million
Company | Market Cap (USD) |
---|---|
Novo Nordisk | $622.07 B |
Vertex Pharmaceuticals Incorporated | $121.36 B |
Regeneron Pharmaceuticals, Inc. | $115.11 B |
CSL Limited | $95.75 B |
Marinomed Biotech AG | $75.67 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
G&E Herbal Biotechnology Co., Ltd., a biotechnology company, focuses on the development and commercialization of novel botanical extraction technology and products in Taiwan. It offers hepato protective agent capsules for the treatment of chronic liver inflammation, cirrhosis, hepatitis, and other liver diseases; botanical anti-aging cosmetic products; and SR-100 skin repair gel. The company also provides botanical healthcare products, such as Astragali Radix for physical strength; Goji for eyes; and Prosta capsule for regulating physiological functions and boosting metabolism, as well as offers adult products. In addition, it is developing Solarise injection for the treatment of gynecological, head, and neck cancer; Apocin capsule for the treatment of lung/breast cancer; and SR-T100 Gel. Further, the company manufactures technology development for various dietary supplements, as well as provides technical advisory services to other biotechnology organizations. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
G&E Herbal Biotechnology Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 4911 wb_incandescent